{"filings":[{"id":1582396,"accession_number":"0001493152-26-032864","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2026-07-10T20:50:56+00:00","items":["7.01","9.01"],"status":"ready","headline":"SRX Global declares $0.05/share dividend, authorizes $20M buyback, reports $3.07 NAV","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["One-time cash dividend of $0.05/share (~$1M aggregate) payable Aug 3, 2026 to holders of record July 22, 2026.","Preliminary NAV of ~$3.07/share, $55M+ cash/short-term investments, no debt as of June 30, 2026.","Board authorized repurchase of up to 10M shares or 50% of outstanding, with $20M allocated, through July 9, 2027.","CEO Kent Cunningham and EMJX President Eric Jackson to host virtual fireside chat on July 14, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1299636,"accession_number":"0001493152-26-030259","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2026-06-26T18:19:05+00:00","items":["7.01","9.01"],"status":"ready","headline":"SRX Global posts investor presentation on website; no substantive details in filing","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Company posted investor presentation on June 26, 2026, available on its website.","Presentation furnished as Exhibit 99.1 but content not summarized in this filing.","No financial results, guidance, or material events disclosed in the body of the 8-K.","Company states it intends to use the presentation with investors and analysts."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1251956,"accession_number":"0001493152-26-029963","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2026-06-24T21:23:15+00:00","items":["3.01","5.07","9.01"],"status":"ready","headline":"SRX Global receives NYSE American delisting notice; approves 1-for-60 reverse split effective July 6","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["NYSE American notified SRX on June 23, 2026 that stock closed below $0.10 and trading halted; company aims to regain compliance via reverse split.","Board and majority shareholders authorized reverse split ratio range of 15-to-1 to 85-to-1; board selected 1-for-60.","Reverse split effective July 6, 2026; stock continues trading under SRXH on NYSE American with new CUSIP.","No fractional shares will be issued; any holder entitled to a fractional share will receive one whole share instead.","Transfer agent Equity Stock Transfer LLC will handle exchange for certificate holders; street-name holders need no action."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1132836,"accession_number":"0001493152-26-029254","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2026-06-18T17:48:57+00:00","items":["7.01","9.01"],"status":"ready","headline":"SRx Health closes EMJX acquisition, changes name to SRX Global, issues 268M+ shares and warrants","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired 100% of EMJ Crypto Technologies and CCC Crypto; issued 268.3M common shares, 117.3M exchangeable shares, and 44.4M warrants.","Company renamed to SRX Global Inc.; stock continues trading under SRXH on NYSE American.","New AI-driven platform strategy focuses on capital allocation into high-conviction operating companies and digital assets.","Management team: Kent Cunningham CEO, Eric Jackson President EMJX & Head of Asset Management, Nina Martinez CFO.","Already invested in Astro Capital, Opendoor (OPEN), Uber (UBER), and Optimi Health."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93025,"accession_number":"0001493152-26-018489","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2026-04-22T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"SRx Health subsidiary invests >10% of investable capital in AI/space SPV","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Halo, Purely for Pets invests >10% of investable capital in Astro Investment XVII, an Astro Capital affiliate SPV.","Investment targets convergence of artificial intelligence and space technology sectors.","SRx is pursuing a definitive merger agreement with EMJ Crypto Technologies (EMJX).","EMJX CEO Eric Jackson highlights long-term value for shareholders from the investment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93024,"accession_number":"0001493152-26-017736","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2026-04-17T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"SRx Health Solutions and EMJX Update Merger Progress, Report Treasury Returns","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Deployed $18M into Gen2 digital-asset treasury hedging strategy, March 2026 return of 5.69% vs S&P 500 decline of 4.98%.","Through mid-April, achieved approximate gains of 3.5% in hedging pool and 8% in long treasury holdings.","Filed Form S-4 registration statement with SEC for proposed merger with EMJ Crypto Technologies.","Company acquired shares of Compass Inc. in open market and increased investment in Opendoor Technologies Inc.","Eric M. Jackson, founder of EMJX, to become officer of EMJC subsidiary following merger closing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104314,"accession_number":"0001493152-26-010911","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2026-03-18T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"SRx Health Solutions raises up to $8.0M via Series B preferred and warrants; initial close $4.528M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Securities Purchase Agreement for up to 10,000 Series B shares ($1,000 stated value) and warrants at $0.3182 exercise price.","Initial closing of 5,660 Series B shares and 22,237,666 warrants for gross proceeds of ~$4.528M.","Warrants expire 3 years from exercisability; exercise price subject to adjustment after stockholder approval.","Company optional redemption at 125% of greater of stated value or market price; conversion price fixed at $0.3182."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104313,"accession_number":"0001493152-26-008656","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2026-03-03T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"SRx Health enters waiver for new Series B preferred stock offering","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Existing investors waive participation rights and consent to Series B Preferred Stock ranking pari passu with Series A.","New offering of Series B Preferred Stock and related warrants planned under a new securities purchase agreement.","Waiver relates to prior July 2025 note financing and October 2025 Series A financing agreements.","Company must file Form 8-K disclosing material non-public information by next business day.","Effective date of waiver is upon receipt of identical agreements from other holders."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104312,"accession_number":"0001493152-26-007565","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2026-02-20T23:59:59+00:00","items":["3.01","9.01"],"status":"ready","headline":"SRx Health Solutions receives NYSE American warning letter over 7.5M share issuance without approval","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["NYSE American issued public warning letter on Feb 18, 2026 citing violations of Sections 301 and 713.","Company failed to file listing application and obtain shareholder approval for issuance of approx. 7.5 million shares upon conversion of Series A Preferred Stock.","Company had obtained stockholder approval by written consent on Oct 8, 2025, but NYSE deemed it deficient under internal guidance.","All preferred shares have been converted or redeemed as of report date; no preferred shares outstanding.","Company filed Form 8-K and press release on Feb 20, 2026 disclosing the warning letter."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104311,"accession_number":"0001493152-26-006259","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2026-02-12T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"SRx Health redeems Series A Preferred for $21.8M, cancels ~125M common shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Redeemed 17,418 Series A Preferred shares at ~$21.77M; all outstanding shares eliminated.","Preferred represented ~125M common shares on as-converted basis, now cancelled, reducing dilution.","Prior private placement on Oct 31, 2025 issued 19,035 shares for $15.23M in proceeds.","Board member cites improved balance sheet flexibility for M&A or capital returns.","Company expects to file Q1 FY2026 Form 10-Q on Feb 13, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104310,"accession_number":"0001493152-26-000926","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2026-01-08T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"NYSE American accepts SRx Health's compliance plan; listing extended to July 14, 2026","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["NYSE accepted plan to regain compliance with Sections 1003(a)(i) and (ii) of the NYSE American Company Guide.","As of June 30, 2025, stockholders' equity was negative $45.9 million, triggering the listing deficiency.","Company will provide quarterly updates to NYSE during the Plan Period through July 14, 2026.","Previously notified of deficiency on October 14, 2025; plan acceptance avoids immediate delisting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120609,"accession_number":"0001493152-25-028965","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2025-12-23T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"SRx Health shareholders OK name change to EMJX, EMJ Crypto acquisition","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved name change to EMJX, Inc. and ticker to EMJX, conditioned on closing of transaction.","Approved issuance of shares (≥20% of outstanding) at below market value to acquire EMJ Crypto Technologies and IP asset (AI algorithm for crypto trading).","Eric M. Jackson appointed CEO and Chairman effective upon closing of the transaction.","Elected directors: Simon Conway, Michael Young, Joshua A. Epstein, Sammy Dorf for term until 2026 annual meeting.","Also approved increase in 2019 Incentive Award Plan to 10% of outstanding shares (min 3,432,915) and ratification of Davidson & Company LLP as auditor."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120608,"accession_number":"0001493152-25-027898","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2025-12-16T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"SRx Health to acquire EMJX in all-stock deal valued at ~$55M; Eric Jackson to become CEO and Chairman","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Aggregate purchase price ~$55M payable in stock; transaction unanimously approved by SRx Health Board.","Closing expected Q1 2026; subject to SRx shareholder approval, SEC filings, listing approval, and other conditions.","Upon closing, Eric M. Jackson (EMJX founder/CEO) to serve as CEO and Chairman of combined company; combined entity to operate under EMJX name.","EMJX is a Gen2 digital-asset treasury platform using quantitative models and AI for multi-asset risk management; target is to reduce reliance on equity dilution.","The IP asset includes an AI algorithm designed to outperform Bitcoin and Ethereum based on trading volatility."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120607,"accession_number":"0001493152-25-024432","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2025-11-20T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"SRx Health Solutions increases authorized common stock from 200M to 5B shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Authorized common shares increased from 200M to 5B via Certificate of Amendment filed Nov 19, 2025.","Stockholders approved the amendment on Oct 8, 2025; effective upon filing with Delaware Secretary of State.","Number of authorized preferred shares remains unchanged at 4 million."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120606,"accession_number":"0001493152-25-021463","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2025-11-10T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"SRx Health Solutions appoints Sammy Dorf to Board of Directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Sammy Dorf appointed as director effective November 10, 2025.","Dorf is Executive Chairman of Flora Growth Corp. (NASDAQ: FLGC) and co-founded Verano Holdings.","He raised over $300M in capital and secured 25+ licenses across 14 states.","Brings expertise in cannabis, crypto, and alternative asset strategy.","Appointment adds regulatory and growth experience to the board."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120605,"accession_number":"0001493152-25-020457","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2025-10-31T23:59:59+00:00","items":["1.01","2.03","3.02","5.02","5.03","9.01"],"status":"ready","headline":"SRx Health raises $15.23M in first closing of Series A preferred offering; secures up to $1B equity commitment","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["First closing of private placement: 19,035 Series A Preferred shares and 54.5M warrants for $15.23M; additional closings at investor option up to $30.46M total.","Amendment to July 2025 Purchase Agreement increased total commitment from $50M to $1B; issued $20M convertible promissory note in connection.","Series A Preferred conversion price fixed at $0.6109; warrants exercisable at $0.6109; company seeks stockholder approval to raise authorized common from 200M to 5B shares.","Directors Lionel F. Conacher and David Allen White resigned Oct 31, 2025; committees reconstituted with Michael Young, Simon Conway and Joshua A. Epstein."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120604,"accession_number":"0001493152-25-018441","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2025-10-17T23:59:59+00:00","items":["3.01","9.01"],"status":"ready","headline":"SRx Health receives NYSE American deficiency notice for stockholders' equity below $4M","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received NYSE American notice on Oct 14, 2025 for non-compliance with Section 1003(a)(ii) due to stockholders' equity below $4M and net losses.","Company must submit compliance plan by Nov 13, 2025 and cure deficiency by July 14, 2026.","No immediate delisting; common stock continues trading on NYSE American under symbol SRXH.","Company is actively developing measures to regain compliance within the cure period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120603,"accession_number":"0001493152-25-017575","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2025-10-09T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"SRx Health stockholders approve 25x share increase and up to 85:1 reverse split","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Authorized shares increased from 200M to 5B; additional reverse split range 15:1 to 85:1 approved.","Issuance above 19.99% outstanding authorized under ELOC Purchase Agreement and July 2025 SPA.","Bylaw quorum lowered from majority to one-third of outstanding shares.","Written consent holders with 51.20% voting power approved all matters; no opposition.","Additional reverse split must occur by March 31, 2026 at Board's discretion."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120602,"accession_number":"0001493152-25-017043","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2025-10-06T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"SRx Health Solutions appoints Joshua Epstein to board and compensation committee","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Joshua A. Epstein appointed to SRx Health Board of Directors, effective October 1, 2025.","He brings over 20 years of experience in energy, healthcare, cannabis, and technology sectors.","Currently head of Corporate Development at Lisbon Valley Mining Co.; former CEO of Socati Corp.","Epstein will also serve on the Board's Compensation Committee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137211,"accession_number":"0001493152-25-014303","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2025-09-19T23:59:59+00:00","items":["4.01","8.01","9.01"],"status":"ready","headline":"SRx Health Solutions dismisses auditor, enters CCAA asset sales; identifies $1.8M revenue error","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dismissed CBIZ CPAs, engaged Davidson & Company as auditor for FY2025 ending Sept 30.","Identified $1.8M revenue overstatement in FY2024; will revise, not restate, statements.","Prior auditors flagged going-concern doubts and multiple material weaknesses (IT controls, revenue recognition).","SRx Canada subsidiary in CCAA creditor protection; majority of assets sold via court-approved transactions.","Material weakness expected related to revenue recognition; additional control deficiencies reported."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137210,"accession_number":"0001641172-25-023868","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2025-08-14T23:59:59+00:00","items":["1.01","5.02","9.01"],"status":"ready","headline":"SRx Health cancels 18.8M shares (60% of total) via settlement; director resigns","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["18.8M shares forfeited and canceled, representing ~60% of total outstanding Common Stock and Exchangeable Shares.","Settlement releases founders from certain claims; SRx Canada subsidiary is under CCAA creditor proceedings.","Board member Adesh Vora resigned effective August 13, 2025, citing SRx Canada's CCAA proceedings.","Company intends to explore legal remedies against former officers not party to the settlement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137209,"accession_number":"0001641172-25-023256","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2025-08-12T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SRx Health Solutions' Canadian subsidiary enters CCAA restructuring; DIP financing obtained","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["SRx Canada obtained Initial Order under CCAA from Ontario Superior Court, including a stay of proceedings.","DIP financing secured of up to $1,750,000 (includes insider participation) for working capital and restructuring.","Court approved a sale process that may result in sale of all or substantially all of SRx Canada's assets.","Company states no impact on U.S. parent or Halo subsidiary; no U.S. bankruptcy filing expected."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137208,"accession_number":"0001641172-25-021348","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2025-07-29T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"SRx Health stockholders approve reverse stock split at ratio up to 60:1 before March 2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders holding 51.5% of voting power (17,088,904 shares) approved Reverse Stock Split via written consent on July 23, 2025.","Board authorized to implement split at ratio between 15-to-1 and 60-to-1, at any time before March 31, 2026.","Exact split ratio and timing remain at Board's sole discretion; no further stockholder vote required.","No votes against, abstaining, or broker non-votes; approval by written consent without a meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137207,"accession_number":"0001641172-25-019864","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2025-07-16T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"SRx Health appoints Kent Cunningham CEO; Adesh Vora becomes Executive Chairman; CFO gets raise","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Adesh Vora resigned as CEO July 8; replaced by Kent Cunningham, previously President.","Cunningham receives $444K base salary, 70% bonus target, and $3M equity award upon profitability.","CFO Carolina Martinez salary increased to $325K retroactively, plus $150K one-time bonus, with clawback within 90 days.","Vora appointed Executive Chairman of the board effective immediately (per press release)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137206,"accession_number":"0001641172-25-019652","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2025-07-15T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"SRx Health closes $7.3M convertible note financing and secures $50M equity line of credit","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Closed $7.3M convertible note financing led by insiders and existing investors; notes bear 8% interest, mature July 2027.","Notes convertible at $0.6274 per share; warrants issued to purchase 21,338,062 shares at $0.6274, exercisable for 3 years.","Secured $50M equity line of credit (ELOC) with a lead investor; $1M in commitment shares issued at a discount to market.","Proceeds to support U.S. M&A pipeline, Canadian specialty pharma expansion, and working capital for growth initiatives.","Company granted security interest in substantially all U.S. business assets as collateral for the note financing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137205,"accession_number":"0001641172-25-018789","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K/A","filed_at":"2025-07-11T23:59:59+00:00","items":["9.01","1.01","2.01","5.01","5.02","5.03","8.01"],"status":"ready","headline":"SRx Health acquires SRx Canada; FY2024 net loss C$59.4M, goodwill impairment C$26.9M, going concern doubt","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["SRx Canada revenue C$200.5M for year ended Sep 30, 2024, net loss C$59.4M vs loss C$15.1M prior year.","Goodwill impairment C$26.9M and intangibles impairment C$2.1M recorded in FY2024.","Auditor's report includes material uncertainty about going concern due to net capital deficiency of C$72.0M.","As of Sep 30, 2024, total liabilities C$117.6M exceed total assets C$45.6M.","Pro forma combined financials filed; business combination closed Apr 24, 2025, with SRx Canada as surviving entity."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":154503,"accession_number":"0001641172-25-015024","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2025-06-13T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"SRx Health Solutions appoints new CEO, President, Chairman and CFO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Davender Sohi resigned as President effective June 10, 2025; no dispute cited.","Kent Cunningham appointed President, Adesh Vora appointed CEO, and Lionel Conacher appointed Chairman, effective June 11, 2025.","Nina Martinez appointed Chief Financial Officer, effective June 11, 2025.","All appointees held prior officer/director roles; base compensation unchanged.","Company refocuses on chronic disease, infusion services, clinical trials, and patient support."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.73,"calibrated_materiality_score":0.73,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":154502,"accession_number":"0001641172-25-009078","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2025-05-07T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"SRx Health Solutions posts updated investor presentation on website","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Company posted updated presentation to its website on May 6, 2025.","Presentation is available in the Investors – Events section of srxhealth.com.","No specific financial updates, guidance, or material changes were disclosed in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":154501,"accession_number":"0001641172-25-007917","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2025-04-30T23:59:59+00:00","items":["2.01","5.01","5.02","5.03","8.01","9.01","3.02"],"status":"ready","headline":"SRx Health completes reverse merger with Better Choice; rename, new board, $8.8M PIPE","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Former SRx Health stockholders own ~84% of combined entity; Better Choice holders retain ~16% (5.4M shares).","$8.8M private placement to single investor at $2.18/share: 4.0M shares + pre-funded warrants.","New board: Adesh Vora (Exec. Chairman), Simon Conway, David White; CEO Kent Cunningham remains.","SRx Health operates 20 specialty pharmacies, 34 infusion clinics across Canada; FY2023 rev CAD$161M.","Halo pet business 17% dividend distributed to Predecessor stockholders on April 23, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":154500,"accession_number":"0001641172-25-006709","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2025-04-29T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"SRx Health Solutions replaces auditor Marcum with CBIZ CPAs; ongoing material weaknesses","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Marcum LLP resigned as auditor April 23, 2025; CBIZ CPAs engaged immediately for FY 2025.","CBIZ CPAs acquired Marcum's attest business effective Nov 1, 2024; audit team unchanged.","Prior Marcum audit reports included going-concern explanatory paragraph for FY 2024.","Unremediated material weaknesses in IT general controls and revenue recognition persist.","No disagreements or reportable events between Company and Marcum during the period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":154499,"accession_number":"0001641172-25-006264","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2025-04-25T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"SRx Health Solutions announces spin-out distribution of Halo SPV shares; ticker change to SRXH effective April 30","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders of record as of April 23, 2025 receive one share of Halo SPV Class A Common Stock per share of common stock held.","Payable date is April 25, 2025; Halo SPV holds 17% of Halo, Purely for Pets, Inc.","Business combination with SRx Health Solutions (Canada) consummated April 24, 2025.","New company name and ticker symbol 'SRXH' take effect on NYSE American on April 30, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":154498,"accession_number":"0001641172-25-005151","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2025-04-17T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Better Choice confirms SRx acquisition consideration of 30M shares; closing targeted April 25","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Addendum fixes aggregate consideration at 30,000,000 Better Choice common shares for SRx shareholders.","Exchange ratio calculated using 30-day VWAP as of April 16, 2025.","Closing expected on or about April 25, 2025, following court and shareholder approvals already obtained.","Transaction is an all-stock acquisition via Canadian statutory arrangement; SRx to become indirect wholly-owned subsidiary."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":154497,"accession_number":"0001641172-25-005149","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2025-04-17T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Better Choice sells Asian business for $8.1M; $6.5M cash upfront, 5-year royalty","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sale of Halo's Asian business to CZC Company LTD for total gross proceeds of $8.1 million.","Upfront cash of $6.5 million ($3.34 per share); minimum $1.65M royalty over 5 years at 3% of sales.","Better Choice retains North American and rest-of-world ex-Asia operations.","Chairman Michael Young says proceeds may fund buybacks, dividends, or allocation into silver/gold/currencies.","Company expects to focus on core health and wellness portfolio."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173050,"accession_number":"0001641172-25-001817","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2025-03-31T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Better Choice shareholders approve name change to SRX Health Solutions and SRx acquisition","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders approved name change to SRX Health Solutions Inc. and ticker to SRXH (FOR 1,359,116 votes).","Approved issuance of up to 30M shares for acquisition of SRx Health Solutions (FOR 1,088,501).","Approved increase in shares under 2019 Incentive Award Plan (FOR 1,026,385).","Adjournment proposal passed but was unnecessary; all proposals received strong FOR majorities."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173049,"accession_number":"0001641172-25-001762","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2025-03-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Better Choice announces Q4/FY2024 results; no specifics provided in filing text","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Press release attached as Exhibit 99.1 but not included in available filing text.","Earnings for Q4 and year ended December 31, 2024 were reported on March 27, 2025.","No financial metrics (revenue, EPS, guidance) are extractable from this filing."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.57,"consensus_revenue_estimate":null,"consensus_revenue_actual":7159000.0,"consensus_period":"2026-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173048,"accession_number":"0001493152-25-007612","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2025-02-20T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Better Choice adjourns special meeting for SRx arrangement to March 21; 71% of shares voted in favor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Special meeting convened and immediately adjourned to March 21, 2025; no business conducted.","Proxies representing ~71% of BTTR shares outstanding submitted, sufficient to approve all proposals including SRx arrangement.","Adjournment allows SRx to pursue shareholder vote and final Ontario court order, and to update on NYSE American listing compliance.","Company will file and mail a proxy supplement; record date remains January 21, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173047,"accession_number":"0001493152-25-003924","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2025-01-28T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Better Choice amends SRx acquisition: valuation cut to $77M, closing deadline extended to Feb 28","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Amendment No. 2 to Arrangement Agreement extends Outside Date from Jan 31, 2025 to Feb 28, 2025.","Equity value attributed to SRx reduced from $80M to $77M; Exchange Ratio revised accordingly.","Plan Amendment clarifies treatment of SRx shares held by Better Choice at closing.","Special meeting for stockholder vote set for Feb 19, 2025; record date Jan 21, 2025.","Transaction remains an all-stock acquisition under Canadian statutory arrangement; subject to approvals."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190081,"accession_number":"0001493152-24-050967","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2024-12-20T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Better Choice Co. reports 2024 annual meeting voting results","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Elected five directors: Conacher, Cunningham, Fronzaglia, Word III, Young (all with >93% FOR votes).","Ratified Marcum LLP as independent auditor for FY2024; 1,104,732 FOR, 540 AGAINST, 2,736 ABSTAIN.","Advisory approval of named executive officer compensation: 744,227 FOR, 39,588 AGAINST, 439 ABSTAIN.","Voter turnout 60.70% (1,108,008 of 1,825,139 shares outstanding).","Broker non-votes: 323,754 on director election and say-on-pay; none on auditor ratification."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190080,"accession_number":"0001493152-24-049472","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2024-12-10T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Better Choice increases Halo spin-out to 17% in SRx Health acquisition amendment","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Amendment to Arrangement Agreement increases Halo spin-out from 8% to 17% for stockholders.","Better Choice to acquire SRx Health Solutions in all-stock transaction via amalgamation.","Transaction approved by both boards; subject to stockholder and court approvals.","Closing conditions include no material adverse effect and regulatory approvals."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190079,"accession_number":"0001493152-24-046243","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2024-11-15T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Better Choice announces Q3 2024 results; no financial details in filing","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Earnings press release issued November 12, 2024 for Q3 ended September 30, 2024.","The exhibit text is not included in the provided filing; specific numbers are unavailable.","Refer to the full press release for revenue, EPS, and segment details."],"consensus_eps_estimate":-0.0612,"consensus_eps_actual":-4.73,"consensus_revenue_estimate":null,"consensus_revenue_actual":200506000.0,"consensus_period":"2024-09-30","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190078,"accession_number":"0001493152-24-043596","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2024-11-05T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Better Choice posts investor presentation referencing proposed SRx deal; proxy solicitation underway","summary_kind":"llm","event_type":"m_and_a","confidence":"low","bullets":["Company filed an updated investor presentation dated Oct 30, 2024 as Exhibit 99.1.","Presentation references a proposed business combination with SRx, previously disclosed.","Filing states the company will prepare and mail a proxy statement for stockholder vote on the transaction.","No deal value, terms, or financial projections were disclosed in the filing.","Presentation is furnished under Regulation FD; not filed or incorporated by reference."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190077,"accession_number":"0001493152-24-041494","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2024-10-18T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Better Choice expects combined 2025 revenue ~$270M, EBITDA ~$10M; SRx Health acquisition close imminent","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Combined 2025 pro forma revenue over $270M and EBITDA over $10M, based on management assumptions.","Transaction expected to close late Q4 2024 or early Q1 2025; all-stock deal valued at ~$125M.","Combined TTM revenue $235M (+25% QoQ); expected annual cost savings ~$1.7M.","Better Choice Q2 2024 adjusted EBITDA near break-even (-$0.03M); SRx Health had CAD$180M revenue in 2023.","Pro forma fully diluted shares 22.9M; insiders own ~75%; net tangible book value $4.07/share."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206577,"accession_number":"0001493152-24-035494","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2024-09-09T23:59:59+00:00","items":["1.01","3.02","7.01","9.01"],"status":"ready","headline":"Better Choice Co. acquires SRx Health Solutions in all-stock deal valuing SRx at $80M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["SRx to be acquired via statutory amalgamation; equity value $80M, assumes $43M net debt subject to two-way adjustment.","Exchange ratio based on 30-day VWAP of BTTR stock, with share collar of 19.75M to 30M shares.","Transaction unanimously approved by both boards; closing requires stockholder and court approvals.","Voting agreement with SRx CEO Adesh Vora to vote all his shares in favor of the transaction."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206576,"accession_number":"0001493152-24-033843","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2024-08-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Better Choice Q2 net income $2.7M (EPS $2.98) vs $3.0M loss YoY; rev down 19%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income of $2.7M in Q2 2024 vs $3.0M loss a year ago; EPS $2.98 vs $(4.27).","Revenue $8.5M, down 19% YoY from $10.5M, but up 8% sequentially from Q1 2024.","Gross margin improved 403 bps to 38%; operating loss improved 72% to $(0.7)M.","Adjusted EBITDA improved 98% to less than $(0.1)M; includes $3.6M gain on debt extinguishment.","Six-month 2024 net loss narrowed to $(0.2)M from $(6.4)M; revenue $16.4M vs $19.8M YoY."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.5,"consensus_revenue_estimate":null,"consensus_revenue_actual":117122000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206575,"accession_number":"0001493152-24-030461","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2024-08-07T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Better Choice exercises over-allotment, raising ~$300K more for total ~$5.3M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Underwriter exercised over-allotment to buy 100,000 shares at $3.00/share on Aug 2, 2024.","Total gross proceeds increased to ~$5.3M from initial ~$5.0M; net proceeds not disclosed.","Over-allotment shares priced same as initial offering; no terms changed.","Original offering comprised 639,000 shares and pre-funded warrants for 1,028,000 shares.","Underwriting discounts and offering expenses still payable; final net proceeds pending."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206574,"accession_number":"0001493152-24-029909","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2024-08-01T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Better Choice raises $5M in public offering of stock and pre-funded warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold 639,000 shares at $3.00 and 1,028,000 pre-funded warrants at $2.99 each.","Gross proceeds of $4,990,720 before underwriting discounts; offering closed July 31, 2024.","Underwriter ThinkEquity LLC granted 45-day option for 100,000 additional shares.","Company and insiders subject to 90-day lock-up; ~273,676 insider shares restricted.","Proceeds intended for general corporate purposes; no specific use stated."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206573,"accession_number":"0001493152-24-027884","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2024-07-15T23:59:59+00:00","items":["3.01","7.01","9.01"],"status":"ready","headline":"NYSE American accepts Better Choice's compliance plan, extends listing through Oct 2025","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["On July 9, 2024, NYSE American accepted Better Choice's plan to regain compliance with continued listing standards.","Stockholders' equity was $1.1M as of March 31, 2024, below the $4M threshold required by Section 1003(a)(i).","Extension granted until October 24, 2025; company to provide quarterly progress updates on its plan.","Company previously disclosed non-compliance on April 24, 2024, due to losses and low equity."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206572,"accession_number":"0001493152-24-027095","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2024-07-12T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Better Choice dismisses BDO, appoints Marcum; BDO's reports had going concern","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["On July 12, 2024, the Board dismissed BDO USA, P.C. as auditor and engaged Marcum LLP for FY2024.","BDO's audit reports for FY2022 and FY2023 contained a going concern qualification but no adverse opinions or disagreements.","Management reported material weaknesses in IT controls, complex transactions, and revenue recognition; IT controls were remediated by March 31, 2024.","No other reportable events or disagreements occurred during the past two fiscal years through July 12, 2024.","BDO furnished a letter (Exhibit 16.1) confirming agreement with the company's disclosures regarding its dismissal."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":223754,"accession_number":"0001493152-24-024626","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2024-06-21T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Better Choice settles Alphia lawsuit, retires $5.0M senior secured debt and warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Retired $5.0M principal + $0.4M PIK interest senior secured debt with Alphia.","Retired 335,640 warrants (strike $11.44) set to expire in 2028.","Eliminated ~$5.0M other indebtedness; potential savings up to $2.7M if paid within 90 days.","Dismisses ongoing litigation; improves balance sheet and reduces dilution."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":223753,"accession_number":"0001493152-24-021350","cik":1471727,"company_name":"SRx Health Solutions, Inc.","ticker":"SRXH","form_type":"8-K","filed_at":"2024-05-24T23:59:59+00:00","items":["3.01","9.01"],"status":"ready","headline":"Better Choice receives NYSE American warning for early Q1 results disclosure without prior notice","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Issued Q1 2024 press release at 12:50 PM ET on May 17, 2024 without notifying exchange 10 minutes prior, violating Section 401(a).","NYSE Regulation sent warning letter dated May 21, 2024; company filed 8-K on May 24, 2024 to disclose noncompliance.","No delisting or suspension imposed; company required to issue news release about the warning per Section 401(j)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":66107943.1689661,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2024-05-24T23:59:59+00:00|223753"}